In our study , 3 different bone marrow-derived stem cell approaches in AMI did not result in improvement of LVEF or volumes compared with standard AMI care ( Trial of Hematopoietic Stem Cells in Acute Myocardial Infarction [ TECAM ] ; NCT00984178 ) .